CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 75 filers reported holding CYTEK BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $11,917,245 | +31.1% | 2,135,707 | +57.6% | 0.00% | 0.0% |
Q1 2024 | $9,091,849 | -22.8% | 1,354,970 | +4.9% | 0.00% | 0.0% |
Q4 2023 | $11,776,273 | +47.6% | 1,291,258 | -10.7% | 0.00% | 0.0% |
Q3 2023 | $7,979,370 | -30.6% | 1,445,538 | +7.4% | 0.00% | 0.0% |
Q2 2023 | $11,497,982 | +1.3% | 1,346,368 | +9.0% | 0.00% | 0.0% |
Q1 2023 | $11,351,543 | +2310.1% | 1,235,206 | +3762.3% | 0.00% | – |
Q3 2022 | $471,000 | +4.9% | 31,981 | -23.2% | 0.00% | – |
Q1 2022 | $449,000 | – | 41,617 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
Miura Global Management | 820,000 | $12,070,000 | 7.24% |
RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
Parkwood LLC | 42,336 | $623,000 | 0.09% |
PDT Partners, LLC | 31,436 | $463,000 | 0.07% |